ACADIA PHARMACEUTICALS INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ACADIA PHARMACEUTICALS INC. stock issued during period, value, new issues for fiscal 2020 was $44.28M, a 83.69% decline from fiscal 2019.
- ACADIA PHARMACEUTICALS INC. stock issued during period, value, new issues for fiscal 2019 was $271.45M, a 9.07% decline from fiscal 2018.
- ACADIA PHARMACEUTICALS INC. stock issued during period, value, new issues for fiscal 2018 was $298.54M.
- ACADIA PHARMACEUTICALS INC. stock issued during period, value, new issues for fiscal 2016 was $497.76M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2020-12-31 | $44.28M 10-K · filed 2023-02-28 | |
| 2019-12-31 | $271.45M 10-K · filed 2022-03-01 | |
| 2018-12-31 | $298.54M 10-K · filed 2021-02-25 | |
| 2016-12-31 | $497.76M 10-K · filed 2019-02-27 | |
| 2014-12-31 | $196.78M 10-K · filed 2017-02-28 | |
| 2013-12-31 | $107.88M 10-K · filed 2016-02-29 | |
| 2011-12-31 | $13.90M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |